Suppression/NN
of/IN
nuclear/JJ
factor/NN
kappa/NN
B/NN
and/CC
CD18-mediated/JJ
leukocyte/NN
adhesion/NN
to/TO
the/DT
corneal/NN
endothelium/NN
by/IN
dexamethasone/NN
./.

PURPOSE/NN
:/:
To/TO
demonstrate/VB
that/IN
leukocyte/NN
adhesion/NN
to/TO
cultured/VBN
corneal/NN
endothelial/JJ
cells/NNS
is/VBZ
mediated/VBN
by/IN
the/DT
CD18/NN
antigen/NN
,/,
and/CC
to/TO
determine/VB
whether/IN
dexamethasone/NN
directly/RB
suppresses/VBZ
adhesion/NN
by/IN
inhibiting/VBG
activation/NN
of/IN
nuclear/JJ
factor/NN
kappa/NN
B/NN
(/(
NFkappaB/NN
)/)
./.
=====
METHODS/NNS
:/:
Cultured/VBN
bovine/JJ
corneal/NN
endothelium/NN
was/VBD
stimulated/VBN
for/IN
6/CD
hours/NNS
by/IN
40/CD
micron/ml/NN
tumor/NN
necrosis/NN
factor/NN
alpha/NN
(/(
TNFalpha/NN
)/)
./.
=====
Dexamethasone/NN
was/VBD
added/VBN
1/CD
hour/NN
before/IN
TNFalpha/NN
stimulation/NN
in/IN
the/DT
dexamethasone/NN
group/NN
./.
=====
After/IN
stimulation/NN
,/,
neutrophils/NNS
separated/VBN
from/IN
a/DT
healthy/JJ
human/JJ
volunteer/NN
were/VBD
added/VBN
with/IN
or/CC
without/IN
anti-CD18/JJ
antibody/NN
./.
=====
The/DT
culture/NN
plate/NN
was/VBD
settled/VBN
for/IN
15/CD
minutes/NNS
at/IN
37/CD
degrees/NNS
C/NN
,/,
and/CC
then/RB
neutrophils/NNS
were/VBD
activated/VBN
by/IN
N-formyl-methionyl-leucyl-phenylalanine/NN
for/IN
5/CD
minutes/NNS
./.
=====
Nonadherent/JJ
neutrophils/NNS
were/VBD
removed/VBN
by/IN
sealing/VBG
and/CC
inverting/VBG
the/DT
culture/NN
well/RB
./.
=====
The/DT
intracellular/JJ
localization/NN
of/IN
NFkappaB/NN
after/IN
TNFalpha/NN
simulation/NN
was/VBD
determined/VBN
by/IN
confocal/JJ
immunocytochemistry/NN
using/VBG
an/DT
anti-p65/JJ
antibody/NN
./.
=====
RESULTS/NNS
:/:
Neutrophil/NN
adhesion/NN
to/TO
cultured/VBN
corneal/NN
endothelial/JJ
cells/NNS
increased/VBD
significantly/RB
on/IN
exposure/NN
to/TO
TNFalpha/NN
(/(
451.4+/-45.4/CD
cells/mm2/NNS
,/,
n/NN
=/JJ
16/CD
)/)
compared/VBN
to/TO
control/NN
(/(
156.7+/-27.3/CD
cells/mm2/NNS
,/,
n/NN
=/JJ
16/CD
,/,
P/NN
</JJR
0.01/CD
)/)
./.
=====
This/DT
increased/VBN
adhesion/NN
was/VBD
suppressed/VBN
by/IN
the/DT
addition/NN
of/IN
anti-CD18/JJ
antibody/NN
(/(
157.6+/-25.1/CD
cells/mm2/NNS
,/,
n/NN
=/JJ
8/CD
,/,
P/NN
</JJR
0.01/CD
)/)
and/CC
by/IN
pretreatment/NN
with/IN
10(-7)/CD
M/NN
dexamethasone/NN
(/(
207.9+/-31.5/CD
cells/mm2/NNS
,/,
n/NN
=/JJ
10/CD
,/,
P/NN
</JJR
0.01/CD
)/)
./.
=====
Immunocytochemistry/NN
60/CD
minutes/NNS
after/IN
stimulation/NN
revealed/VBD
that/IN
NFkappaB/NN
was/VBD
located/JJ
in/IN
the/DT
cytoplasm/NN
in/IN
unstimulated/JJ
cells/NNS
;/:
however/RB
,/,
the/DT
addition/NN
of/IN
TNFalpha/NN
caused/VBD
NFkappaB/NN
to/TO
translocate/VB
into/IN
the/DT
nucleus/NN
./.
=====
Pretreatment/NN
with/IN
dexamethasone/NN
tapered/VBD
NFkappaB/NN
translocation/NN
into/IN
the/DT
nucleus/NN
./.
=====
CONCLUSIONS/NNS
:/:
Leukocyte/NN
adhesion/NN
to/TO
the/DT
corneal/NN
endothelium/NN
was/VBD
shown/VBN
to/TO
be/VB
mediated/VBN
by/IN
CD18/NN
expressed/VBN
on/IN
activated/VBN
leukocytes/NNS
./.
=====
Pretreatment/NN
of/IN
the/DT
endothelium/NN
with/IN
dexamethasone/NN
inhibited/VBD
leukocyte/NN
adhesion/NN
;/:
this/DT
may/MD
be/VB
due/JJ
in/IN
part/NN
to/TO
the/DT
suppression/NN
of/IN
NFkappaB/NN
entry/NN
into/IN
the/DT
nucleus/NN
./.